Status:
COMPLETED
Effects of UC-II, Glucosamine and Curcumin Supplementation on Knee Pain and Inflammation.
Lead Sponsor:
Taipei Medical University
Conditions:
Inflammation
Knee Pain Chronic
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
This research evaluated the effects of UCII, glucosamine and curcumin supplementation on knee pain and inflammation.
Detailed Description
Arthritis is an inflammation of one or more joints, characterized by pain, stiffness (especially in the early morning or after exercise), swelling, deformation, and/or reduced mobility. There are many...
Eligibility Criteria
Inclusion
- Knee plain
Exclusion
- Severe diseases of the heart, liver, kidneys, endocrine system, and other organs
- Long-term use of medication
- Infection, hypertension, diabetes, cerebrovascular disease, heart disease, liver disease, kidney disease, gastrointestinal disease
- Allergy to this product
Key Trial Info
Start Date :
August 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 3 2024
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06581094
Start Date
August 20 2024
End Date
December 3 2024
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei medical university
Taipei, Taiwan